Seeing Is Believing
Currently out of the existing stock ratings of Chris Lewis, 25 are a BUY (100%).
Analyst Chris Lewis, carries an average stock price target met ratio of 100% that have a potential upside of 21.42% achieved within 172 days. Previously, Chris Lewis worked at ROTH MKM, FIRST ANALYSIS.
Chris Lewis’s has documented 67 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AXGN, Axogen at 12-Sep-2017.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for GKOS (GLAUKOS CORP) at 4/14/2016. The price target of $24 was fulfilled within 20 days with a profit of $5.77 (31.65%) receiving and performance score of 15.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-Oct-2025
$175
$25.11 (16.75%)
$188
Buy Since 25-Mar-2025
$200
$50.11 (33.43%)
$200
10 days ago
(22-Oct-2026)
11/17 (64.71%)
$44.49 (28.61%)
180
Buy Since 01-May-2025
$205
$55.11 (36.77%)
$235
11 days ago
(21-Oct-2026)
17/57 (29.82%)
$53.63 (35.43%)
95
Buy Since 18-Oct-2017
$162
$12.11 (8.08%)
$250
17 days ago
(15-Oct-2026)
20/30 (66.67%)
$12.66 (8.48%)
101
Buy Since 17-Oct-2025
$215
$65.11 (43.44%)
$172
18 days ago
(14-Oct-2026)
3/5 (60%)
$70.56 (48.85%)
40